Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 806, pseudogene (RN7SL806P)

Target
RN7SL806P
Molecular classification
Pseudogene, Non-coding RNA (pseudogenic), Other
01

Overview

RNA, 7SL, cytoplasmic 806, pseudogene (RN7SL806P) is classified as a pseudogene—a DNA sequence that closely resembles a functional gene but is generally non-functional due to mutations or truncations that prevent normal RNA or protein production[8][9]. The RN7SL family includes sequences derived from the 7SL RNA, a crucial component of the signal recognition particle (SRP) required for targeting proteins to the endoplasmic reticulum[3][5][11]. However, RN7SL806P itself is not known to produce a functional RNA product and is considered a genomic remnant, likely formed through reverse transcription and insertion of 7SL RNA into the genome[7][8]. Pseudogenes of 7SL, such as RN7SL806P, are numerous in the genome and are, by definition, usually not expressed or associated with direct biological functions or clinical significance. There are no records of this specific pseudogene serving as a direct therapeutic target, biomarker, or drug interaction site[9][8][6]. Summary: - RN7SL806P is a non-coding pseudogene related to the functional 7SL RNA component of the signal recognition particle, but is itself non-functional and not considered a therapeutic target. - No associated drugs, mechanisms of action, biomarkers, or safety concerns are reported. - It primarily serves as a genomic reference with no established biological or clinical role.

Other names
RN7SL806P
02

Mechanism of action

None

03

Biological functions

None established (for pseudogene itself)Pseudogenes in the RN7SL family do not typically encode protein nor are they generally functionally active[7][8][9]
04

Disease associations

Other (no established direct disease association for RN7SL806P specifically; some pseudogenes can have regulatory roles, but there is no evidence for RN7SL806P[4][7])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 806, pseudogene (RN7SL806P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 806, pseudogene (RN7SL806P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call